Isolated Rectal Bleeding in Newborns : Allergic Proctocolitis or Neonatal Colitis Transient - COLON Study

Sponsor
Centre Hospitalier Universitaire de Nice (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06088537
Collaborator
(none)
40
36.5

Study Details

Study Description

Brief Summary

Prospective observational pilot study evaluating the frequency of cow's milk protein allergic prococolitis in newborns hospitalized in neontal medicine at the university hospital of Nice who presented rectal bleeding.

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    Inclusion of all newborns in the neonatal medicine department at Nice University Hospital with isolated rectal bleeding.

    A note of information and non-opposition will be presented and given to the biological mother. She has the right to object to this study, on her own initiative, at any time.

    Collection of data relating to the newborn during hospitalization, the results of the clinical examination and the systematic check-up carried out in accordance with standard practice, and data at discharge.

    Follow-up of the newborn to determine the cause of rectal bleeding and therefore the frequency of procolitis allergic to cow's milk proteins.

    Prospective observational study of current practices without any intervention.

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    40 participants
    Observational Model:
    Other
    Time Perspective:
    Prospective
    Official Title:
    Isolated Rectal Bleeding in Newborns : Allergic Proctocolitis or Neonatal Colitis Transient - COLON Study
    Anticipated Study Start Date :
    Oct 16, 2023
    Anticipated Primary Completion Date :
    Oct 30, 2026
    Anticipated Study Completion Date :
    Oct 30, 2026

    Outcome Measures

    Primary Outcome Measures

    1. Number of newborns allergic to cow's milk protein and hospitalized in neonatal medicine at Nice University Hospital with isolated rectorrhagia. [3 years]

      The main objective of this study is to determine the number of newborns presenting real allergic proctocolitis to cow's milk protein among all newborns hospitalised in neonatal medicine who presented with isolated rectal bleeding in order to determine the frequency of this pathology. If rectal bleeding disappears when cow's milk proteins are eliminated and reappears when cow's milk proteins are reintroduced, the diagnosis of allergic proctocolitis to cow's milk proteins will be confirmed. In other cases, newborns will be considered to have had transient neonatal colitis. Then this study will determine the frequency of these two diseases in the population study.

    Secondary Outcome Measures

    1. Identify risk factors for developing transient neonatal colitis. [3 years]

      To determine these risk factors, the study will compare the characteristics of newborns with allergic protocolitis to cow's milk proteins with those of newborns with transient neonatal colitis. The parameters compared between the two groups will be as follows: gestational age at birth, route of delivery, antibiotic therapy prior to rectal bleeding, type of diet (mother's milk or artificial milk) family history of allergy.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    1 Day to 28 Days
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. All newborns ≤ 28 days corrected age or ≤ 44 amenorrhea weeks corrected age hospitalized in neonatal medicine with isolated rectorrhagia;

    2. Affiliated to social security ;

    3. Presenting isolated rectorrhagia defined as rectorrhagia without hematemesis/ repeated vomiting/ tense or distended abdomen/ apathy/ apnea/ bradycardia or signs of severity (tachycardia, desaturation, poor coloration);

    4. After obtaining the biological mother's non-objection;

    Exclusion Criteria:
    1. All newborns with ulcerative enterocolitis, congenital digestive malformations or rectorrhagia following digestive surgery;

    2. Opposition to participation in research involving the human person.

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire de Nice

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire de Nice
    ClinicalTrials.gov Identifier:
    NCT06088537
    Other Study ID Numbers:
    • 23-PP-05
    First Posted:
    Oct 18, 2023
    Last Update Posted:
    Oct 18, 2023
    Last Verified:
    Oct 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire de Nice
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Oct 18, 2023